Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$35.21 - $47.3 $66,899 - $89,870
-1,900 Reduced 15.45%
10,400 $440,000
Q2 2024

Aug 14, 2024

SELL
$30.43 - $53.43 $1.26 Million - $2.21 Million
-41,400 Reduced 77.09%
12,300 $495,000
Q1 2024

May 15, 2024

BUY
$22.09 - $35.41 $247,408 - $396,591
11,200 Added 26.35%
53,700 $1.9 Million
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $65,688 - $142,738
4,600 Added 12.14%
42,500 $1.26 Million
Q3 2023

Nov 14, 2023

BUY
$19.33 - $36.22 $523,842 - $981,562
27,100 Added 250.93%
37,900 $787,000
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $50,778 - $89,166
2,100 Added 24.14%
10,800 $265,000
Q1 2023

May 15, 2023

SELL
$35.86 - $46.5 $46,618 - $60,450
-1,300 Reduced 13.0%
8,700 $353,000
Q4 2022

Feb 14, 2023

BUY
$35.49 - $56.15 $99,372 - $157,220
2,800 Added 38.89%
10,000 $449,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $68.97 $315,072 - $496,584
7,200 New
7,200 $345,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.